FLNA
Filana Therapeutics·NASDAQ
--
--(--)
--
--(--)
7.44 / 10
Outperform
Analyst coverage is limited but overwhelmingly positive: one analyst issued a Strong Buy, yielding a 100% bullish consensus. Fund‑flow patterns show solid inflows (overall ratio 0.45) despite negative trends across size segments, indicating supportive liquidity.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-10-06
InstitutionLUCID CAPITAL MARKETS
Times predicted1
Historical Win Rate100.0%
What is the market sentiment for FLNA?
- FLNA holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.44/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
